Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid, Malignant Tumors”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01222546
What this trial is testing

Study of CH5132799 Administered Orally in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Chugai Pharma Europe Ltd. 38
Early research (Phase 1)Study completedNCT00020488
What this trial is testing

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Early research (Phase 1)WithdrawnNCT05262842
What this trial is testing

JS001+IMP4297 in Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Shanghai Junshi Bioscience Co., Ltd.
Early research (Phase 1)Looking for participantsNCT07042100
What this trial is testing

Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Sun Pharma Advanced Research Company Limited 177
Early research (Phase 1)Ended earlyNCT01093092
What this trial is testing

Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Adult Solid Neoplasm
Roswell Park Cancer Institute 14
Early research (Phase 1)Study completedNCT01454804
What this trial is testing

Pazopanib, Lapatinib or Trastuzumab in Subjects With Solid Tumors

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 43
Early research (Phase 1)Study completedNCT03250832
What this trial is testing

Study of TSR-033 With an Anti-programmed Cell Death-1 Receptor (PD-1) in Participants With Advanced Solid Tumors

Who this might be right for
Neoplasms
Tesaro, Inc. 111
Testing effectiveness (Phase 2)Ended earlyNCT04552704
What this trial is testing

CD24Fc for the Treatment of Immune Related Adverse Events in Patients With Advanced Solid Tumors, TIRAEC Study

Who this might be right for
Advanced Malignant Solid Neoplasm
Tianhong Li 3
Early research (Phase 1)Looking for participantsNCT06241898
What this trial is testing

A First-in-human of Multiplle Doses of BB-1709 in Subjects With Locally Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Bliss Biopharmaceutical (Hangzhou) Co., Ltd 300
Early research (Phase 1)Looking for participantsNCT07252414
What this trial is testing

GenSci143 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Changchun GeneScience Pharmaceutical Co., Ltd. 180
Early research (Phase 1)UnknownNCT05461287
What this trial is testing

Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd. 290
Testing effectiveness (Phase 2)Looking for participantsNCT06840821
What this trial is testing

Evaluating the Safety, Tolerability, and Preliminary Anti-tumor Activity of MB0151 in Adult Subjects With Advanced Solid Tumors Expressing Somatostatin Receptors

Who this might be right for
Advanced Solid Tumors
Mainline Biosciences (Shanghai) Co., Ltd 156
Testing effectiveness (Phase 2)Study completedNCT01267084
What this trial is testing

Assess the Potential Effects of Ketoconazole on the Pharmacokinetics of Trabectedin in Patients With Advanced Malignancies

Who this might be right for
Neoplasm Metastases
Janssen Research & Development, LLC 12
Early research (Phase 1)UnknownNCT05768321
What this trial is testing

Study of GEC255 in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation

Who this might be right for
Advanced Solid Tumors
GenEros Biopharma Hangzhou Ltd 70
Early research (Phase 1)Study completedNCT05564806
What this trial is testing

Study of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Advanced Solid TumorsRelapsed Or Refractory Non-Hodgkin Lymphoma
Eucure (Beijing) Biopharma Co., Ltd 9
Early research (Phase 1)Study completedNCT03667716
What this trial is testing

COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.

Who this might be right for
Advanced CancerOvarian CancerBreast Cancer+7 more
Compugen Ltd 121
Early research (Phase 1)Active Not RecruitingNCT06993116
What this trial is testing

A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Guangdong Hengrui Pharmaceutical Co., Ltd 15
Early research (Phase 1)Study completedNCT00390052
What this trial is testing

3-AP in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01364844
What this trial is testing

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Who this might be right for
Solid TumorColorectal CancerEndometrial Cancer
Daiichi Sankyo 42
Testing effectiveness (Phase 2)Ended earlyNCT01562899
What this trial is testing

MEK162 and AMG 479 in Patients With Selected Solid Tumors

Who this might be right for
Metastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma
Pfizer 77
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation